$ELV

EVP at Elevance Health (NYSE: ELV) now holds 6,530 shares after tax withholding

Elevance Health (ELV) reported that EVP & Chief HR Officer Ryan R. Craig had 144 shares withheld for taxes on Sept 2, 2026, due to restricted stock vesting. The shares were valued at $405.84 each, leaving Craig with 6,530 shares. No Rule 10b5-1 trading plan was involved.

Original reporting
Published Sep 4, 2026, 8:07 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 6, 2026, 6:41 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$ELV
Neutral
high confidence
Mentioned
$ELV
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$ELVNeutralLow
01

Why it matters

The disclosed transaction is minor and does not alter the company's capital structure or outlook.

02

Market read

Limited relevance; primarily of interest to shareholders tracking insider activity.

03

What to watch

Potential future dilution if more restricted stock vests, but current impact remains minimal.

Relevance 4/10Novelty 5/10Timing: September 2, 2026 filing date

Background

Elevance Health (ELV) filed a Form 4 reporting a tax‑withholding disposition for its EVP & Chief HR Officer.

Company-level read

Ticker impact

$ELVNeutralHigh confidence
Context

Form 4 disclosed EVP & Chief HR Officer Ryan R. Craig had 144 shares withheld for tax on Sep 2, 2026, holding 6,530 shares.

Expected impact

No material price impact expected.

Evidence & confidence

The transaction size is minor relative to market cap and no future sale plan is indicated.

Market effects

None; insider tax withholding is routine and does not signal sector trends.

None; limited to Elevance Health shareholders.

None

Counterpoint

Even small insider transactions can hint at insider confidence, but the lack of a 10b5‑1 plan suggests no strategic intent.

Key entities

  • Ryan R. Craig

    EVP & Chief HR Officer of Elevance Health

  • Elevance Health

    U.S. health insurance provider (NYSE: ELV)

Related articles

$ELVHighAI 8/10

AI Efficiency Gains And Behavioral Health Push Could Be A Game Changer For Elevance Health (ELV)

Elevance Health (ELV) reported stronger Q2 2026 results, raising full-year EPS guidance to at least $20.10. The company highlighted AI-driven efficiency gains and appointed a new leader for its behavioral health services. Analysts note potential margin improvements but caution about elevated medical costs and policy risks. Revenue and earnings projections for 2029 are $209.8 billion and $7.3 billion, respectively.

$ELVHighAI 9/10

Elevance Health Stock Outlook: Is Wall Street Bullish or Bearish?

Elevance Health (ELV) has a market cap of $86.9B. Its stock rose 27.6% over 52 weeks, outperforming the S&P 500. Q2 2026 revenue was $49.8B, adjusted EPS $7.45. The company raised EPS and cash flow guidance. Analysts expect a 10.3% YOY EPS decline for 2026, but ELV has beaten estimates for four straight quarters. The consensus rating is 'Moderate Buy' with a mean price target of $445.71.

$ELVMed

Elevance accuses Hamaspik of poaching staff to copy its plans

Elevance Health filed a complaint on July 27, 2026, in the US District Court for the Southern District of New York against managed care organization Hamaspik, Inc. and four of its own former employees. According to the filing, Hamaspik has run a "coordinated scheme" since December 2025 to hire the people who run Elevance's New York Managed Long-Term Care (MLTC) and Fully Integrated Dual Eligible Special Needs (FIDE) plans, which combine Medicare and Medicaid coverage in a single product.